ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,667.56
0.08%
Dow Jones
41,985.35
0.08%
US Dollar vs MXN
20.2392
0.48%
Brent Oil
71.775
-0.13%
Bitcoin
84,115.12
-0.02%
Pepperstone
Advertisement
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ

  6. Day One Biopharmaceuticals Inc (DAWN) Cotización

Day One Biopharmaceuticals Inc

Day One Biopharmaceuticals Inc (DAWN)

NASDAQ
8.23
-0.10
(-1.20%)
Al cierre: 21 Marzo 2:00PM
Delayed by 15 minutes
8.23
0.00
( 0.00% )
Fuera de horario: 2:05PM
Delayed by 15 minutes

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Premium

Estadísticas y detalles clave

Último Precio
8.23
Postura de Compra
8.23
Postura de Venta
8.49
Volume Operado de la Acción
1,688,303
8.11 Rango del Día 8.30
7.88 Rango de 52 semanas 18.0699
Capitalización de Mercado [m]
834.148M
Precio Anterior
8.33
Precio de Apertura
8.23
Hora
25
@
8.23
Última hora de negociación
17:03:57
Volumen financiero
US$ 13,856,996
Precio Promedio Ponderado
8.2076
Volumen promedio (3 m)
1,184,598
Acciones en circulación
101,354,516
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-8.73
Beneficio por acción (BPA)
-0.94
turnover
131.16M
Beneficio neto
-95.5M

Acerca de Day One Biopharmaceuticals Inc

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with c... Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The lead product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, kinase inhibitor. Mostrar más

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
www.dayonebio.com
Sede
Wilmington, Delaware, USA
Fundado
-
Day One Biopharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker DAWN. The last closing price for Day One Biopharmaceuticals was US$8.33. Over the last year, Day One Biopharmaceuticals shares have traded in a share price range of US$ 7.88 to US$ 18.0699.

Day One Biopharmaceuticals currently has 101,354,516 shares in issue. The market capitalisation of Day One Biopharmaceuticals is US$844.28 million. Day One Biopharmaceuticals has a price to earnings ratio (PE ratio) of -8.73.

DAWN Últimas noticias

Más noticias

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Edgar (US Regulatory)
06 Marzo 2025
DAWN (-1.20%)

Form 3 - Initial statement of beneficial ownership of securities
Edgar (US Regulatory)
28 Febrero 2025
DAWN (-1.20%)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Edgar (US Regulatory)
25 Febrero 2025
DAWN (-1.20%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
21 Febrero 2025
DAWN (-1.20%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
18 Febrero 2025
DAWN (-1.20%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
31 Enero 2025
DAWN (-1.20%)

Form 8-K - Current report
Edgar (US Regulatory)
13 Enero 2025
DAWN (-1.20%)

Form S-8 - Securities to be offered to employees in employee benefit plans
Edgar (US Regulatory)
10 Enero 2025
DAWN (-1.20%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
12 Diciembre 2024
DAWN (-1.20%)

Form 8-K - Current report
Edgar (US Regulatory)
20 Noviembre 2024
DAWN (-1.20%)
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.55-6.264236902058.788.898.0410944608.28880377CS
4-4.15-33.5218093712.3812.577.8815727169.13789268CS
12-4.63-36.003110419912.8613.537.88118459810.72970113CS
26-6.66-44.728005372714.8916.767.88112589812.49956363CS
52-6.67-44.765100671114.918.06997.88108745013.55677379CS
156-2.67-24.49541284410.928.34995.4491658214.63846876CS
260-16.77-67.082528.6995.4475876614.82422534CS

DAWN - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Day One Biopharmaceuticals?
El precio actual de las acciones de Day One Biopharmaceuticals es US$ 8.23
¿Cuántas acciones de Day One Biopharmaceuticals están en circulación?
Day One Biopharmaceuticals tiene 101,354,516 acciones en circulación
¿Cuál es la capitalización de mercado de Day One Biopharmaceuticals?
La capitalización de mercado de Day One Biopharmaceuticals es USD 844.28M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Day One Biopharmaceuticals?
Day One Biopharmaceuticals ha negociado en un rango de US$ 7.88 a US$ 18.0699 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Day One Biopharmaceuticals?
El ratio precio/beneficio de Day One Biopharmaceuticals es -8.73
¿Cuál es el ratio de efectivo a ventas de Day One Biopharmaceuticals?
El ratio de efectivo a ventas de Day One Biopharmaceuticals es 6.36
¿Cuál es la moneda de reporte de Day One Biopharmaceuticals?
Day One Biopharmaceuticals presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Day One Biopharmaceuticals?
El último ingresos anual de Day One Biopharmaceuticals es USD 131.16M
¿Cuál es el último beneficio anual de Day One Biopharmaceuticals?
El último beneficio anual de Day One Biopharmaceuticals es USD -95.5M
¿Cuál es la dirección registrada de Day One Biopharmaceuticals?
La dirección registrada de Day One Biopharmaceuticals es 251 LITTLE FALLS DRIVE, NEW CASTLE, WILMINGTON, DELAWARE, 19808
¿Cuál es la dirección del sitio web de Day One Biopharmaceuticals?
La dirección del sitio web de Day One Biopharmaceuticals es www.dayonebio.com
¿En qué sector industrial opera Day One Biopharmaceuticals?
Day One Biopharmaceuticals opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
IMTEIntergrated Media Technology Ltd
US$ 0.8001
(48.19%)
1.32M
TCBPTC BioPharm Holdings PLC
US$ 0.723
(44.60%)
3.86M
BSGMBioSig Technologies Inc
US$ 0.7428
(36.27%)
125.15k
WINTWindtree Therapeutics Inc
US$ 1.73
(16.89%)
1.18M
RGCRegencell Bioscience Holdings Ltd
US$ 68.20
(16.32%)
60.39k
NVNINVNI Group Ltd
US$ 0.1748
(-28.01%)
3.6M
LGHLLion Group Holding Ltd
US$ 0.0789
(-20.78%)
588.61k
GNLNGreenlane Holdings Inc
US$ 0.3465
(-18.95%)
116.05k
QVCGBQVC Group Inc
US$ 5.50
(-16.92%)
496
SHFSSHF Holdings Inc
US$ 0.2619
(-14.44%)
13.89k
DMNDamon Inc
US$ 0.0377
(1.07%)
19.24M
CSCOCisco Systems Inc
US$ 60.1877
(-0.19%)
8.2M
SGLYSingularity Future Technology Ltd
US$ 1.5407
(-8.29%)
7.43M
YHCLQR House Inc
US$ 0.4568
(14.20%)
6.6M
NVDANVIDIA Corporation
US$ 117.66
(-0.03%)
6.01M

Discusión

Ver feed completo
FOFreddie FOFreddie 5 minutos hace
Hi Rodney - I owned FMCC in 2008 and I started buying during the summer with the expectation that the UST would get warrants in exchange for infusing more capital. I had expected the UST to keep paying the dividends on JPS because all of the small banks that owned the JPS would be wiped out. FMC
FMCC
PEACHMAN PEACHMAN 5 minutos hace
IF this is how butterknife is growing pot it explains why he is obviously unable to absorb due diligence on IFUS.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175960276
IFUS
hedge_fun hedge_fun 6 minutos hace
Unlike the government for the past decades, it……

will need to be reconciled.

It could be as simple as asset sales, impairment, foreign currency fluctuation, or a combination of all of them.

They won’t be able to sweep it under the rug like the folks in
BigBadWolf BigBadWolf 6 minutos hace
It’s getting 2EZ for All to see for themselves as
$ASIInvestors $Continued $Affirmation of @BubbyGotTaken $Agenda?? so again ask yourselves why as you
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175958643
TakenPainfully2 it appears
https://investo
AFFIRMATIO AGENDA ASIINVESTO
Joe Kaplan Joe Kaplan 7 minutos hace
scott re your statement..... "Yes back then NAK was fun to trade" , I agree with you.

And YES, NAK is still fun to trade today, especially when on the right side of the trade and making a profit.
NAK
PEACHMAN PEACHMAN 7 minutos hace
Your mixing up reports from HCR42 and scientific data from IFUS testing and data from universities and tests in India..

No wonder you are completely inaccurate.

The government tests were not about IFUS ..They were general tests over I believe 3 months to find commercial
IFUS
gail gail 7 minutos hace
they said monday, but thats all i…

…

know, i cant post or communicate there.
AGH
lettruthringout lettruthringout 7 minutos hace
Five million shares showing up after hours.

Didn't move the needle. Must be dark web sales or something.
WTTR
Jackxkr Jackxkr 8 minutos hace
I believe she's screwed this up to the point where second mouse gets the cheese.
NWBO
BullNBear52 BullNBear52 10 minutos hace
Evidently people enrolled at NYU never venture elsewhere in NYC. Especially art history student

As Janice has pointed out NYU had an art building near the Guggenheim and at one time they had an uptown campus as well as the campus down in the Village.

I know more about t
PegnVA PegnVA 10 minutos hace
LOL!!!
$PennyMover $PennyMover 11 minutos hace
https://x.com/SippIndustries/status/1903155544766157036
SIPC
DAR53 DAR53 11 minutos hace
FWIW, I just had a thought regarding Amarin's new attorney. It makes sense to me that she would have a conversation with Marjac regarding some of the past legal issues we have had. Perhaps North40000 as well. She needs to be an apex predator in these legal proceedings.
AMRN
SSKILLZ1 SSKILLZ1 12 minutos hace
Points Off Average Victory For 2025

Commentary: Hope Everyone enjoys these statistics
[pre]
Alias # Of Wins Point Off Points Off Average
BULLNBEAR52 13 197 15.15
SSKILLZ1 7 372 53.14
[/pre]
COMP
PegnVA PegnVA 12 minutos hace
Donald Trump may not leave the White House at the end of his term..."may"???
$7.00 or Nothing $7.00 or Nothing 12 minutos hace
My 0.03% which is not of elite is one share each of 15 stocks with potential.

2 of them were bought. One of them got bankrupt lol.
ELTP
955 955 12 minutos hace
It's pretty clear Pulte was told to stop posting inside information after Patswil posting Pulte reply to his X post on the other board. Seems only Congress is entitled to those privileges. It's about time we get business types back in office to restore power back to the people rather than bureaucr
SSKILLZ1 SSKILLZ1 13 minutos hace
% # Of Wins For 2025

Commentary: Hope Everyone enjoys these statistics.
[pre]
Alias # Of Wins % Of Wins
NO WINNER 34 62.96%
BULLNBEAR52 13 24.07%
SSKILLZ1 7 12.96%
Totals 54 100.00%
[/pre]
COMP
nowwhat2 nowwhat2 13 minutos hace
Fascinating.....

https://investorshub.advfn.com/uimage/uploads/2025/3/21/ohfqnxrp_~_21_1m_345pm_FASCINATING_OHTL_DIAG.jpg




https://investorshub.advfn.com/uimage/uploads/2025/3/21/wksotETH_~_20_5Y_HYPER_10PM_2000.jpg



XRPUSD
chen1992 chen1992 13 minutos hace
This is it guys, permits on hand, we now await a few more contracts and the all important FID with R/M. 2025 is our year!

Anyone reading this… get your .30s before it’s too late!!
TGLO
SSKILLZ1 SSKILLZ1 13 minutos hace
Points Off Average Victory For March

Commentary: Hope Everyone enjoys these statistics
[pre]
Alias # Of Wins Point Off Points Off Average
BULLNBEAR52 3 51 17.00
SSKILLZ1 1 33 33.00
[/pre]
COMP
WebSlinger WebSlinger 13 minutos hace
****BREAKING*****ANOTHER 300K SHARES DILUTED****

The Scumbag CEO diluted another 300,000 shares.....

The O/S increased from 1,043,046,733 to 1,043,346,733 today. 📉

That puts the runn
KBLB
BigMoneyChalupa BigMoneyChalupa 13 minutos hace
I’ve always loved the OTC due to not having aggressive naked shorting practices. The market reflects the true sentiment of retail investors for the most part and is much less artificial.
ZHUD
SSKILLZ1 SSKILLZ1 14 minutos hace
% # Of Wins For March

Commentary: Hope Everyone enjoys these statistics
[pre]
Alias # Of Wins % Of Wins
NO WINNER 11 73.33%
BULLNBEAR52 3 20.00%
SSKILLZ1 1 6.67%
Totals 15 100.00%
[/pre]
COMP
Bubae Bubae 14 minutos hace
Dude? You have no idea what you are talking about as usual kid. Completely clueless.
Dude who bought up those 4 billion shares in early November

You are BSFor the period ending September 30, 2024
https://www.otcmarkets.com/otcapi/company/financial-report/420298/conten
RDAR

Su Consulta Reciente

NASDAQ
DAWN
Day One Biopharmaceuticals
COIN
ACUUSD
Aitheon
COIN
ARXUST
ARCS
COIN
TABUSD
Accounting Blockchain Token
USOTC
ACIBF
Accion Ibex 35 ETF FI (CE)
AQSE
FDM.GB
FDM
NASDAQ
CCLP
CSI Compressco
NASDAQ
EVOJ
Evo Acquisition
COIN
ATSETH
Authorship
CXIO
USDTGBP
Tether USD
BOV
RANI3Q
CELULOSE IRANI ON
USOTC
SFRT
Appreciate (CE)
COIN
XMXUST
XMax
LSE
ACP
Armadale Capital
BTRX
ANTETH
Aragon Network Token
USOTC
SDCCQ
SmileDirectClub (CE)
Delayed Upgrade Clock
ADVFN Logo
México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados

Quitar anuncios

Suscríbete a una experiencia sin publicidad

Sin anuncios

Pruébalo ahora

Mantenga los anuncios